(Acta Obstet Gynecol Scand 2017;96:1382–1390)
There is a critical need to improve recognition of women at risk of obstetric venous thromboembolism (VTE), which is a leading cause of maternal morbidity and mortality. While venous thromboembolism risk assessment (VTERA) is recommended internationally for all pregnant and postpartum women, VTERA compliance is reportedly poor due to a lack of validated tools for VTERA, unclear optimal thresholds for the initiation of thromboprophylaxis as evidenced by significant variation in guidelines from various organizations, and challenges of assessing women individually in high-throughput environments. This study aimed to develop, pilot and implement an electronic tool for VTERA in a high-throughput setting, and assess compliance with the risk assessment tool. It did not assess clinical outcomes.